In addition, Wei et al.4 discovered that FTO facilitates lipid accumulation in NAFLD by suppressing the expression of the peroxisome proliferator-activated receptor α (PPARα). The gene discussed is FTO; the disease is metabolic dysfunction-associated steatotic liver disease.